Immutep Limited (IMMP) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 2 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for IMMP is $4.25, representing a +681.3% upside from the current price of $0.544. Price targets range from a low of $3.50 to a high of $5.00.
